These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9453495)

  • 1. Increased adrenomedullin levels in cirrhosis: relationship with hemodynamic abnormalities and vasoconstrictor systems.
    Guevara M; Ginès P; Jiménez W; Sort P; Fernández-Esparrach G; Escorsell A; Bataller R; Bosch J; Arroyo V; Rivera F; Rodés J
    Gastroenterology; 1998 Feb; 114(2):336-43. PubMed ID: 9453495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of increased plasma adrenomedullin concentration in patients with cirrhosis.
    Kojima H; Tsujimoto T; Uemura M; Takaya A; Okamoto S; Ueda S; Nishio K; Miyamoto S; Kubo A; Minamino N; Kangawa K; Matsuo H; Fukui H
    J Hepatol; 1998 May; 28(5):840-6. PubMed ID: 9625320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating adrenomedullin in cirrhosis: relationship to hyperdynamic circulation.
    Fernández-Rodriguez CM; Prada IR; Prieto J; Montuenga LM; Elssasser T; Quiroga J; Moreiras M; Andrade A; Cuttitta F
    J Hepatol; 1998 Aug; 29(2):250-6. PubMed ID: 9722206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenomedullin, a vasodilator peptide implicated in hemodynamic alterations of liver cirrhosis: relationship to nitric oxide.
    Genesca J; Gonzalez A; Catalan R; Segura R; Martinez M; Esteban R; Groszmann RJ; Guardia J
    Dig Dis Sci; 1999 Feb; 44(2):372-6. PubMed ID: 10063925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
    Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
    Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma adrenomedullin levels in patients with hepatic cirrhosis.
    Fábrega E; Casafont F; Crespo J; de la Peña J; San Miguel G; de las Heras G; García-Unzueta MT; Amado JA; Pons-Romero F
    Am J Gastroenterol; 1997 Oct; 92(10):1901-4. PubMed ID: 9382062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma endothelin-1 and -3 in cirrhosis: relationship with systemic hemodynamics, renal function and neurohumoral systems.
    Bernardi M; Gulberg V; Colantoni A; Trevisani F; Gasbarrini A; Gerbes AL
    J Hepatol; 1996 Feb; 24(2):161-8. PubMed ID: 8907569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daily profile of plasma endothelin-1 and -3 in pre-ascitic cirrhosis: relationships with the arterial pressure and renal function.
    Trevisani F; Colantoni A; Gerbes AL; Gülberg V; Sica G; Caraceni P; De Notariis S; Morselli-Labate AM; Ligabue A; Gasbarrini G; Bernardi M
    J Hepatol; 1997 Apr; 26(4):808-15. PubMed ID: 9126793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of substance P in liver cirrhosis: relationship to the activation of vasopressor systems and urinary sodium excretion.
    Fernández-Rodriguez CM; Prieto J; Quiroga J; Zozoya JM; Andrade A; Núñez M; Sangro B; Penas J
    Hepatology; 1995 Jan; 21(1):35-40. PubMed ID: 7528711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of single dose of 50mg captopril in patients with liver cirrhosis and ascites.
    Lee JK; Hsieh JF; Tsai SC; Ho YJ; Kao CH
    Hepatogastroenterology; 2000; 47(33):767-70. PubMed ID: 10919029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effects of chronic smoking in liver cirrhosis: a role for adrenomedullin.
    Alonso-Martínez JL; Anniccherico-Sánchez FJ; Urbieta-Echezarreta M; Garcia-Sanchotena JL; Olaz-Preciado F
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):513-8. PubMed ID: 20216319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal sympathetic and renal response to sodium restriction in compensated cirrhosis.
    Simón MA; Díez J; Prieto J
    Gastroenterology; 1991 Nov; 101(5):1354-60. PubMed ID: 1936807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dipyridamole on kidney function in cirrhosis.
    Llach J; Ginès P; Arroyo V; Salmerón JM; Ginès A; Jiménez W; Gaya J; Rivera F; Rodés J
    Hepatology; 1993 Jan; 17(1):59-64. PubMed ID: 8423042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impairment of renal function during moderate physical exercise in cirrhotic patients with ascites: relationship with the activity of neurohormonal systems.
    Saló J; Guevara M; Fernández-Esparrach G; Bataller R; Ginès A; Jimenez W; Ginès P; Rivera F; Arroyo V; Rodés J
    Hepatology; 1997 Jun; 25(6):1338-42. PubMed ID: 9185749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenomedullin in cirrhotic and non-cirrhotic portal hypertension.
    Tahan V; Avsar E; Karaca C; Uslu E; Eren F; Aydin S; Uzun H; Hamzaoglu HO; Besisik F; Kalayci C; Okten A; Tozun N
    World J Gastroenterol; 2003 Oct; 9(10):2325-7. PubMed ID: 14562402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating endogenous cannabinoid anandamide and portal, systemic and renal hemodynamics in cirrhosis.
    Fernández-Rodriguez CM; Romero J; Petros TJ; Bradshaw H; Gasalla JM; Gutiérrez ML; Lledó JL; Santander C; Fernández TP; Tomás E; Cacho G; Walker JM
    Liver Int; 2004 Oct; 24(5):477-83. PubMed ID: 15482346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary endothelin-like immunoreactivity in patients with cirrhosis.
    Saló J; Fernández-Esparrach G; Ginès P; Ginès A; Guevara M; Sort P; Jiménez W; Arroyo V; Rivera F; Rodés J
    J Hepatol; 1997 Nov; 27(5):810-6. PubMed ID: 9382967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased plasma levels of neuropeptide Y in hepatorenal syndrome.
    Uriz J; Ginès P; Ortega R; Jiménez W; Cárdenas A; Calahorra B; Sort P; Fernández J; Bataller R; Arroyo V; Rivera F; Rodés J
    J Hepatol; 2002 Mar; 36(3):349-55. PubMed ID: 11867178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interrelationships between systemic hemodynamics, urinary sodium excretion, and renin-angiotensin system in cirrhosis.
    Aliaga L; Zozoya JM; Omar M; Mediavilla JD; Prieto J
    Acta Gastroenterol Belg; 1995; 58(2):213-21. PubMed ID: 7571982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.